Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study
- DOI
- 10.25122/jml-2023-0459
- Published
- 2023-12
- Container
- Journal of Medicine and Life
- Publisher
- S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.25122/jml-2023-0459,
title = {Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study},
author = {Alfredo José Firstenfeld and Unknown and Jorge Listorti and Unknown and Nasser Jalaff and Unknown and Claudia Patricia Loaiza Orozco and Unknown and Francisco Navarrete Gosdenovich and Unknown and Timo Schurr and Unknown},
year = {2023},
journal = {Journal of Medicine and Life},
doi = {10.25122/jml-2023-0459},
url = {https://doi.org/10.25122/jml-2023-0459}
}RIS
TY - JOUR TI - Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study AU - Alfredo José Firstenfeld AU - Unknown AU - Jorge Listorti AU - Unknown AU - Nasser Jalaff AU - Unknown AU - Claudia Patricia Loaiza Orozco AU - Unknown AU - Francisco Navarrete Gosdenovich AU - Unknown AU - Timo Schurr AU - Unknown PY - 2023 JO - Journal of Medicine and Life DO - 10.25122/jml-2023-0459 UR - https://doi.org/10.25122/jml-2023-0459 ER -
APA
Firstenfeld, A. J., Unknown, Listorti, J., Unknown, Jalaff, N., Unknown, Orozco, C. P. L., Unknown, Gosdenovich, F. N., Unknown, Schurr, T., & Unknown (2023). Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study. Journal of Medicine and Life. https://doi.org/10.25122/jml-2023-0459
Source records
- crossref · retrieved 2026-09-26T17:11:49.616Z